Overview
Hypophosphatemic Rickets in Norway
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Haukeland University HospitalTreatments:
Alfacalcidol
Hydroxycholecalciferols
Sevelamer
Criteria
Inclusion Criteria:- All patients in the Norwegian population with hereditary hypophosphatemia, with or
without rickets
- Patients in the Norwegian population with hereditary hyperphosphatemia
Exclusion Criteria:
-